Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Nature Chemistry|August 24, 2011
The transcription factor FOXM1 is a cellular target of the natural product thiostreptonNagaratna S Hegde, Deborah A Sanders, Raphaël Rodriguez, et al.Cardiovascular Research|December 9, 2010
Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signallingTereza Cindrova-Davies, Deborah A Sanders, Graham J Burton, et al.Genome Biology|January 26, 2013
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cellsDeborah A Sanders, Caryn S Ross-Innes, Dario Beraldi, et al.Genome Biology|June 24, 2015
FOXM1 binds directly to non-consensus sequences in the human genomeDeborah A Sanders, Michael V Gormally, Giovanni Marsico, et al.BMC Genomics|January 20, 2011
MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphismsMuna Affara, Benjamin J Dunmore, Deborah A Sanders, et al.Organic & Biomolecular Chemistry|July 14, 2012
Pyridostatin analogues promote telomere dysfunction and long-term growth inhibition in human cancer cellsSebastian Müller, Deborah A Sanders, Marco Di Antonio, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Targeting the c-Kit Promoter G-quadruplexes with 6-Substituted IndenoisoquinolinesMallesham Bejugam, Mekala Gunaratnam, Sebastian Müller, et al.Journal of the American Chemical Society|February 8, 2011
G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cellsKeith I E McLuckie, Zoë A E Waller, Deborah A Sanders, et al.Nature Communications|November 13, 2014
Suppression of the FOXM1 transcriptional programme via novel small molecule inhibitionMichael V Gormally, Thomas S Dexheimer, Giovanni Marsico, et al.Elife|May 11, 2023
High-grade serous ovarian carcinoma organoids as models of chromosomal instabilityMaria Vias, Lena Morrill Gavarró, Carolin M Sauer, et al.Pageof 2